Doc Malik avatar

Dexa/Doc Malik

Learn more
Published Jan 16, 2024

#116 - Robert Malone MD, Inventor of mRNA & DNA vaccines & Freedom Fighter

Robert Malone, the pioneer of mRNA and DNA vaccines, explores contentious issues surrounding controlled opposition accusations, vaccine safety, and the role of pharmaceutical companies. Engaging with Ahmad Malik, Malone offers critical insights into mRNA technology, pandemic preparedness, and the complex dynamics of public health policies.
Episode Highlights
Doc Malik logo

Topics covered

Popular Clips

Episode Highlights

  • mRNA History

    and discuss the historical development of mRNA technology. Robert explains that the technology has been in development for decades, with significant contributions from both academia and industry. He emphasizes that the rapid deployment of mRNA vaccines was not a sudden breakthrough but the result of years of research and development.

    Anybody that says that this was all done in a year has no idea of what's been going on in the industry. They're clueless. It's been developed for a long time now.

    ---

    Ahmad questions the speed at which the technology was adapted for COVID-19 vaccines, to which Robert responds by detailing the extensive groundwork laid over the years 1 2.

       

    Collaborations

    The conversation shifts to the role of industry collaborations in advancing mRNA vaccine technology. Robert highlights the partnerships between pharmaceutical companies and government agencies, which were crucial for the rapid development and distribution of vaccines. He also points out the long-term investments in manufacturing capabilities that made this possible.

    This industry has been developed for about 15 to 20 years now. Remember my patents expired years ago.

    ---

    Ahmad and Robert discuss how these collaborations have led to a pipeline of new products and technologies, emphasizing the importance of ongoing innovation 3 4.

       

    Alternatives

    Robert explores various alternative technologies that could be used for pandemic preparedness. He mentions monoclonal antibodies, high-throughput drug screening, and other vaccine technologies as potential solutions. The discussion also touches on the need for rapid response mechanisms to address emerging infectious diseases.

    There is a need to be able to come up with a countermeasure on short notice for either engineered or emerging infectious disease.

    ---

    Ahmad and Robert agree on the importance of having multiple approaches to tackle future pandemics, highlighting the complexity and necessity of such efforts 5 6.

Related Episodes